Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is an established diagnosis in children, associated with a large body of evidence on the benefits of treatment. Adolescents with ADHD are now leaving children’s services often with no readily identifiable adult service to support them, which presents problems as local pharmacy regulations often preclude the prescription of stimulant drugs by general practitioners (GPs). In addition, adults with ADHD symptoms are now starting to present to primary care and psychiatry services requesting assessment and treatment. For these reasons, the British Association for Psychopharmacology (BAP) thought it timely to hold a consensus conference to review the body of evidence on childhood ADHD and the growing literature on ADHD in older age groups. Much of this initial guidance on managing ADHD in adolescents in transition and in adults is based on expert opinion derived from childhood evidence. We hope that, by the time these guidelines are updated, much evidence will be available to address the many directions for future research that are detailed here.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent national guidelines now recommend that ADHD should be recognised and appropriately treated throughout the lifespan [32-34].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [34]
In the citing paper
“Psychostimulant medications are associated with disrupted or disturbed sleep”
From Associations of sleep disturbance with ADHD: implications for treatment (2015) · cites this paper as Nutt et al. 2007
Citations
Cites
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,639
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716 · cited 2×
“Scales such as the Clinical Global Adjustment Scale (Shaffer et al., 1983), the ADHD checklists (Adler et al.”
MethodWillcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.006 · Cited by 3,568 · cited 2×
“…– e.g. delay aversion, executive motor inhibition, deficit in arousal/activation regulation) that may underpin symptoms and behaviours, with neurobiological changes (e.g. dysfunction in frontostriatal circuitry, reward systems and catecholamine function (Waldman, 2005; Willcutt et al., 2005)).”
BackgroundKESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 3×
“1, Adler et al., 2004; Kessler et al., 2005) is patient-rated while the ADHD Rating Scale (ADHDRS-IV-Inv, Adler et al., 2005b) is clinician administered with good reliability and moderate agreement between raters.”
BackgroundMethod(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357 · cited 3×
“…double-blind placebo-controlled trials have confirmed the efficacy of atomoxetine in children and adolescents (Thomason and Michelson, 2004 Ib), and similar findings with an effect size of 0.35–0.4 have been reported from two trials in adults (Michelson et al., 2003; Faraone et al., 2005a Ib).”
BackgroundResultInfluentialFARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267 · cited 3×
“…double-blind placebo-controlled trials have confirmed the efficacy of atomoxetine in children and adolescents (Thomason and Michelson, 2004 Ib), and similar findings with an effect size of 0.35–0.4 have been reported from two trials in adults (Michelson et al., 2003; Faraone et al., 2005a Ib).”
BackgroundResultInfluentialAttention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
SPRAFKIN, J., & CARLSON, G. A. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1266 · Cited by 1,900
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646 · cited 2×
“These and other findings (e.g. that brain abnormalities may not determine phenotype (Castellanos et al., 2002 IIa)) could suggest a greater importance of environmental factors in some individuals, both in childhood and in older age groups.”
BackgroundRisperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574 · cited 1×
“Conversely, the effect of atypical antipsychotics on ADHD symptoms particularly hyperactivity in ASD is good, with an effect size of 1.4 (McCracken et al., 2002 Ia).”
BackgroundInfluentialBARKLEY, R. A., FISCHER, M., EDELBROCK, C. S., & SMALLISH, L. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199007000-00007 · Cited by 1,507 · cited 1×
“…studies have documented the natural history of ADHD, especially as patients transit through adolescence into adulthood (Hechtman and Weiss, 1983; Barkley et al., 1990; Weiss and Hechtman, 1993; Biederman et al., 1996a; Biederman et al., 1996b; Faraone et al., 1996; Biederman et al., 1998;…”
BackgroundBiederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498 · cited 2×
“%) or adulthood (10–66%; Hill and Schoener, 1996; Spencer et al., 1996; Faraone et al., 1996; Biederman et al., 2000; Barkley, 2002; Faraone et al., 2006).”
Background(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.885 · Cited by 1,421 · cited 1×
“It relies on retrospective recall by the individual but has been validated against parent report and found to be reliable (Ward et al., 1993).”
BackgroundAttention-Deficit/Hyperactivity Disorder: A Selective Overview
Biederman, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.020 · Cited by 1,351 · cited 4×
“Furthermore, predictors of persistence into adulthood include family history of ADHD, psychiatric co-morbidity and psychosocial adversity (Biederman, 2005).”
BackgroundInfluentialClinical guidelines: Developing guidelines
Shekelle, P. G., Woolf, S. H., Eccles, M., & Grimshaw, J. (1999) · BMJ · doi:10.1136/bmj.318.7183.593 · Cited by 1,222 · cited 1×
“Categories of evidence for causal relationships, observational relationships and strength of recommendations are given in Table 1 and are taken from Shekelle et al. (1999).”
BackgroundCharacterizing cognition in ADHD: beyond executive dysfunction
Castellanos, F. X., Sonuga-Barke, E. J. S., Milham, M. P., & Tannock, R. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.01.011 · Cited by 1,170 · cited 2×
“…that causation is likely to show marked heterogeneity, and/or that traditional theories on cause and effect in ADHD, that regard ADHD as a homogeneous condition characterized by a single causal pathway, are inadequate (Sonuga-Barke, 2003, 2005; Coghill et al., 2005; Castellanos et al., 2006).”
BackgroundSelf-citationAttention-deficit hyperactivity disorder : a clinical workbook
Barkley, R. A., & Murphy, K. R. (1991) · Guilford Press eBooks · Cited by 1,162
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · cited 2×
“In contrast, atomoxetine causes a selective increase in cFos within the prefrontal cortex without increasing expression within the nucleus accumbens or striatum, consistent with it being a selective inhibitor of NET as indicated from in vitro data (Bymaster et al., 2002).”
BackgroundSonuga-Barke, E. J. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.008 · Cited by 962 · cited 3×
“…that causation is likely to show marked heterogeneity, and/or that traditional theories on cause and effect in ADHD, that regard ADHD as a homogeneous condition characterized by a single causal pathway, are inadequate (Sonuga-Barke, 2003, 2005; Coghill et al., 2005; Castellanos et al., 2006).”
BackgroundSelf-citationLEVY, F., HAY, D. A., McSTEPHEN, M., WOOD, C., & WALDMAN, I. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199706000-00009 · Cited by 956 · cited 1×
“Mathematical modelling using De Fries and Fulker (DF) analysis supports the hypothesis that ADHD is the extreme of behaviours that vary genetically throughout the entire population (Gjone et al., 1996; Levy et al., 1997; Willcutt et al., 2000; Price et al., 2001).”
MethodAnderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Self-citationFarrington, D. P. (1995) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1995.tb01342.x · Cited by 903 · cited 1×
“ADHD seems likely to represent a frequent part of the developmental sequence to criminal behaviour (Farrington, 1995 IV), since it contributes to problems at school, which can lead to exclusion and a subsequent change in culture and association with individuals with similar behaviours.”
BackgroundPsychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition
Sonuga-Barke, E. J. S. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00432-6 · Cited by 901 · cited 2×
“However as suggested above, the traditional neuropsychological model of ADHD, which holds that symptoms are the product of a common core deficit expressed by all affected individuals, is now contentious (Sonuga-Barke, 2002, 2003, 2005; Castellanos et al., 2006).”
BackgroundSelf-citationVolkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885 · cited 1×
“Nonetheless, imaging studies indicate that methylphenidate binds strongly to DAT and indirect evidence suggests that this elevates dopamine levels within an hour when given in therapeutic doses by oral administration (Volkow et al., 1998; Krause et al., 2000).”
BackgroundWilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830 · cited 2×
“%) or adulthood (10–66%; Hill and Schoener, 1996; Spencer et al., 1996; Faraone et al., 1996; Biederman et al., 2000; Barkley, 2002; Faraone et al., 2006).”
BackgroundThe dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics
Sonuga-Barke, E. J. S. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.005 · Cited by 816 · cited 3×
“…that causation is likely to show marked heterogeneity, and/or that traditional theories on cause and effect in ADHD, that regard ADHD as a homogeneous condition characterized by a single causal pathway, are inadequate (Sonuga-Barke, 2003, 2005; Coghill et al., 2005; Castellanos et al., 2006).”
BackgroundSelf-citationFrazier, T. W., Demaree, H. A., & Youngstrom, E. A. (2004) · Neuropsychology · doi:10.1037/0894-4105.18.3.543 · Cited by 792 · cited 1×
“The limited liter- ature in adults reports similar patterns, although marked heterogeneity exists (Schoeclin and Engel, 2005; Frazier et al., 2004; Harvey et al., 2004; Seidman et al., 2004; Nigg, 2005).”
BackgroundAtomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790 · cited 1×
“…double-blind placebo-controlled trials have confirmed the efficacy of atomoxetine in children and adolescents (Thomason and Michelson, 2004 Ib), and similar findings with an effect size of 0.35–0.4 have been reported from two trials in adults (Michelson et al., 2003; Faraone et al., 2005a Ib).”
ResultInfluentialNeuropsychology of Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review.
Hervey, A. S., Epstein, J. N., & Curry, J. F. (2004) · Neuropsychology · doi:10.1037/0894-4105.18.3.485 · Cited by 781
A Prospective 4-Year Follow-up Study of Attention-Deficit Hyperactivity and Related Disorders
Biederman, J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050073012 · Cited by 771 · cited 3×
“…co-morbid disorders in adulthood include anxiety, depression and antisocial behaviour disorders, and persisting neurodevelopmental disorders such as dyslexia (Heiligenstein and Keeling, 1995; Biederman et al., 1996b; Marks et al., 2001; Biederman, 2004; McGough et al., 2005; Kessler et al., 2006).”
BackgroundVolkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770 · cited 1×
“Moreover, other groups have reported that methylphenidate treatment, which increases extracellular dopamine in the human striatum (Volkow et al., 2001), is accompanied by reductions in DAT binding to control values (Dresel et al., 2000; Spencer et al., 2005a; Volkow et al., 2005).”
BackgroundAdult psychiatric status of hyperactive boys grown up
Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P., & LaPadula, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.4.493 · Cited by 769 · cited 2×
“Several major prospective follow-up studies have documented the natural history of ADHD, especially as patients transit through adolescence into adulthood (Hechtman and Weiss, 1983; Barkley et al., 1990; Weiss and Hechtman, 1993; Biederman et al., 1996a; Biederman et al., 1996b; Faraone et al., 1996; Biederman et al.,…”
BackgroundClinical correlates of inpatient suicide
Busch, K. A., Fawcett, J., & Jacobs, D. G. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0105 · Cited by 750
Kuo, F. E., & Faber Taylor, A. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.9.1580 · Cited by 741 · cited 1×
“Activities in natural ‘green’ settings have been linked with symptom improvement in a national sample (Kuo and Taylor, 2004 I).”
BackgroundMajor life activity and health outcomes associated with attention-deficit/hyperactivity disorder.
Barkley, R. A. (2002) · PubMed · Cited by 737
ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS
Wender, P. H. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70039-3 · Cited by 728 · cited 1×
“Thus, the consensus group thought it would be helpful to present an extended checklist of adult symptoms in this document, based on childhood diagnostic symptoms plus additional adult symptoms (APA, 2000; WHO, 1992; Wender, 1995).”
BackgroundBarkley, R. A., Grodzinsky, G., & DuPaul, G. J. (1992) · Journal of Abnormal Child Psychology · doi:10.1007/bf00916547 · Cited by 724 · cited 1×
“…studies in children reveal that tests of executive function and attention show good positive predictive power but poor negative predictive power (Barkley et al., 1992; Sharma et al., 1991; Grodzinsky and Barkley, 1999; Rielly et al., 1999; Doyle et al., 2000; Dickerson Mayes et al., 2001;…”
BackgroundBush, G., Valera, E. M., & Seidman, L. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.034 · Cited by 714 · cited 2×
“Neuroimaging studies (Bush et al., 2005) have documented significant overall and regional reductions in white matter volumes between unmedicated ADHD patients, including those never exposed to relevant medication, and healthy controls (Castellanos et al., 2002).”
BackgroundDopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684 · cited 1×
“…compared with controls in ADHD patients (Krause et al., 2000; Madras et al., 2002; Spencer et al., 2005a; Volkow et al., 2005) including studies in adults (Dougherty et al., 1999; Dresel et al., 2000; Krause et al., 2000), suggesting increased density of the transporter protein in the striatum.”
BackgroundEuropean clinical guidelines for hyperkinetic disorder ? first upgrade
Taylor, E., D�pfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1002-x · Cited by 682 · cited 2×
“Recent guidelines are available on management of children with ADHD from the European Society for Child and Adolescent Psychiatry (Taylor et al., 2004; Banaschewski et al., 2006) and the Global ADHD Working Group (Remschmidt and Global ADHD Working Group, 2005), and a suggested protocol for the…”
BackgroundSelf-citationStructural Brain Imaging of Attention-Deficit/Hyperactivity Disorder
Seidman, L. J., Valera, E. M., & Makris, N. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.019 · Cited by 676 · cited 1×
“These studies have clearly demonstrated differences in the anatomy and processing of patients with ADHD compared with controls, although these differences do not have the sensitivity or specificity in individuals to contribute to differential diagnosis (Seidman et al., 2005).”
BackgroundBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617 · cited 1×
“Recent guidelines have covered management of bipolar disorder (Goodwin, 2003) and drug treatments for addiction (Lingford-Hughes et al., 2004), with guidelines on anxiety published late last year (Baldwin et al., 2005).”
BackgroundSelf-citationSergeant, J. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.010 · Cited by 589
Weiss, G. (1986) · Cited by 582
The impact of reinforcement contingencies on AD/HD: A review and theoretical appraisal
Luman, M., Oosterlaan, J., & Sergeant, J. A. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.11.001 · Cited by 541 · cited 1×
“Alternate theories include a failure of specific response-inhibition mechanisms (Willcutt et al., 2005), altered reward or motivational pathways (Luman et al., 2005), abnormal processing of time-related cues (Toplak and Tannock, in submission), non-working memory (Rhodes et al., 2004, 2005) and…”
BackgroundGenotype Influences In Vivo Dopamine Transporter Availability in Human Striatum
Heinz, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00099-8 · Cited by 538 · cited 1×
“In addition, there is evidence from two out of four studies that the DAT1 risk genotype for ADHD is associated with increased striatal DAT binding (Heinz et al., 2000; Jacobsen et al., 2000; Martinez et al., 2001; Cheon et al., 2003).”
BackgroundKrause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521 · cited 3×
“…studies, though not all (van Dyck et al., 2002), have indicated that striatal DAT binding is increased compared with controls in ADHD patients (Krause et al., 2000; Madras et al., 2002; Spencer et al., 2005a; Volkow et al., 2005) including studies in adults (Dougherty et al., 1999; Dresel et…”
BackgroundResultCognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms
Safren, S. A., Otto, M. W., Sprich, S., Winett, C. L., Wilens, T. E., & Biederman, J. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.07.001 · Cited by 519 · cited 2×
“Group therapy, where available, may help with social isolation, especially around the critical period where treatment initiation can enhance experience of failure and lead to loss of self-esteem, depression and substance use (Safren et al., 2005a).”
BackgroundNigg, J. T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.011 · Cited by 513 · cited 1×
“The limited liter- ature in adults reports similar patterns, although marked heterogeneity exists (Schoeclin and Engel, 2005; Frazier et al., 2004; Harvey et al., 2004; Seidman et al., 2004; Nigg, 2005).”
BackgroundWhat Is the Prevalence of Adult ADHD? Results of a Population Screen of 966 Adults
Faraone, S. V., & Biederman, J. (2005) · Journal of Attention Disorders · doi:10.1177/1087054705281478 · Cited by 503 · cited 1×
“…criteria, but will vary depending on clinical measures used and the precise way in which the diagnostic criteria are applied (Hill and Schoener, 1996; Gallagher and Blader, 2001; Bloom and Dey, 2004; Faraone and Biederman, 2005; Kooij et al., 2005; Kessler et al., 2006; Faraone et al., 2006).”
BackgroundWENDER, P. H., WOLF, L. E., & WASSERSTEIN, J. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05770.x · Cited by 498
The epidemiology of attention‐deficit/hyperactivity disorder (ADHD): A public health view
Rowland, A. S., Lesesne, C. A., & Abramowitz, A. J. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10036 · Cited by 495 · cited 1×
“Some evidence suggests that equal numbers of women and men are affected with ADHD as adults (Murphy and Barkley, 1996; Rowland et al., 2002), which raises the possibility that girls with ADHD are underdiagnosed.”
BackgroundAman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & Risperidone Disruptive Behavior Study Group (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1337 · Cited by 475 · cited 1×
“Other treatments for ADHD have been poorly evaluated in LD children, although risperidone has been found useful for treating disruptive behaviours, such as hyperactivity, aggression and impulsivity (Aman et al., 2002 IIa).”
BackgroundSANDRA KOOIJ, J. J., BUITELAAR, J. K., van den OORD, E. J., FURER, J. W., TH. RIJNDERS, C. A., & HODIAMONT, P. P. G. (2005) · Psychological Medicine · doi:10.1017/s003329170400337x · Cited by 468 · cited 2×
“Epidemiological data support the validity of applying a lower threshold in adults (e.g. four or five out of nine criteria), as this lower threshold correlates significantly with impairment (Kooij et al., 2005).”
BackgroundHyperactivity and Conduct Problems as Risk Factors for Adolescent Development
TAYLOR, E., CHADWICK, O., HEPTINSTALL, E., & DANCKAERTS, M. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199609000-00019 · Cited by 454 · cited 1×
“Community follow-up of young people with untreated ‘hyperactivity’ suggests that impulsiveness declines in absolute terms, but remains deviant relative to that of age-matched peers (Taylor et al., 1996).”
BackgroundSelf-citationAdults with ADHD. An overview.
Wender, P. H., Wolf, L. E., & Wasserstein, J. (2001) · PubMed · Cited by 435
Faraone, S. V., Spencer, T., Aleardi, M., Pagano, C., & Biederman, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000108984.11879.95 · Cited by 404 · cited 3×
“While it is not known whether all findings in children can be extrapolated to adults, psychostimulants have comparable effects in adults as in children and adolescents (Faraone et al., 2004; Kooij et al., 2004; Spencer et al., 2005b 1a).”
BackgroundMethodResultMcGough, J. J., Smalley, S. L., McCracken, J. T., Yang, M., Del’Homme, M., Lynn, D. E., & Loo, S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1621 · Cited by 399 · cited 1×
“…co-morbid disorders in adulthood include anxiety, depression and antisocial behaviour disorders, and persisting neurodevelopmental disorders such as dyslexia (Heiligenstein and Keeling, 1995; Biederman et al., 1996b; Marks et al., 2001; Biederman, 2004; McGough et al., 2005; Kessler et al., 2006).”
Background(2001) · Europe PMC (PubMed Central) · Cited by 393
Goodwin, G. M. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017002003 · Cited by 390 · cited 1×
“Recent guidelines have covered management of bipolar disorder (Goodwin, 2003) and drug treatments for addiction (Lingford-Hughes et al., 2004), with guidelines on anxiety published late last year (Baldwin et al., 2005).”
BackgroundSpencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., Mick, E., Aleardi, M., Herzig, K., & Faraone, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.043 · Cited by 385 · cited 5×
“While it is not known whether all findings in children can be extrapolated to adults, psychostimulants have comparable effects in adults as in children and adolescents (Faraone et al., 2004; Kooij et al., 2004; Spencer et al., 2005b 1a).”
BackgroundMethodResultInfluentialRichardson, A. J., & Puri, B. K. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00254-8 · Cited by 378 · cited 1×
“…dietary manipulations can improve ADHD symptoms in at least some children (Egger et al., 1985; Carter et al., 1993; Boris and Mandel, 1994; Rowe and Rowe, 1994; Schmidt et al., 1997; Dykman and Dykman, 1998; Richardson and Puri, 2002 Ib), although the mechanism of these improvements is unknown.”
BackgroundBanaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., et al. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0549-0 · Cited by 375
Self-citationBabinski, L. M., Hartsough, C. S., & Lambert, N. M. (1999) · Journal of Child Psychology and Psychiatry · doi:10.1017/s002196309800362x · Cited by 371
Volkow, N. D., Wang, G.-J., Fowler, J. S., & Ding, Y.-S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.006 · Cited by 368 · cited 3×
“…that striatal DAT binding is increased compared with controls in ADHD patients (Krause et al., 2000; Madras et al., 2002; Spencer et al., 2005a; Volkow et al., 2005) including studies in adults (Dougherty et al., 1999; Dresel et al., 2000; Krause et al., 2000), suggesting increased density of…”
BackgroundHesslinger, B., Tebartz van Elst, L., Nyberg, E., Dykierek, P., Richter, H., Berner, M., & Ebert, D. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0379-0 · Cited by 366 · cited 1×
“In 15 patients, dialectical behaviour therapy showed improvements in ADHD symptoms, depression and functioning compared to control treatment (Hesslinger et al., 2002 IIa).”
MethodThe dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action
Andersen, P. H. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90363-4 · Cited by 346 · cited 1×
“Methylphenidate is a potent inhibitor of dopamine reuptake (Andersen, 1989; Thomason and Michelson, 2004), by binding to the cocaine-binding site on the DAT, but in vitro data on reuptake inhibition suggest that it also has a very high affinity for the norepinephrine transporter (NET).”
BackgroundCONTROLLED TRIAL OF OLIGOANTIGENIC TREATMENT IN THE HYPERKINETIC SYNDROME
Egger, J., Graham, P. J., Carter, C. M., Gumley, D., & Soothill, J. F. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91206-1 · Cited by 326 · cited 1×
“In terms of treatment, various dietary manipulations can improve ADHD symptoms in at least some children (Egger et al., 1985; Carter et al., 1993; Boris and Mandel, 1994; Rowe and Rowe, 1994; Schmidt et al., 1997; Dykman and Dykman, 1998; Richardson and Puri, 2002 Ib), although the mechanism of…”
BackgroundBrookes, K.-J., Mill, J., Guindalini, C., Curran, S., Xu, X., Knight, J., Chen, C.-K., Huang, Y.-S., Sethna, V., Taylor, E., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.74 · Cited by 322 · cited 1×
“Gene–environment interactions have been reported between DAT1 and maternal use of tobacco (Kahn et al., 2003) and alcohol (Brookes et al., 2006) during pregnancy on the risk of ADHD, and between catechol O-methyltransferase and low birth weight on risk for antisocial outcomes among ADHD cases…”
BackgroundSelf-citationHyperactive Children Grown Up: Empirical Findings and Theoretical Considerations
Low, N. L. (1987) · Neurology · doi:10.1212/wnl.37.4.731-a · Cited by 322
Kuczenski, R., & Segal, D. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07264.2002 · Cited by 316 · cited 2×
“Fone K C, Nutt D J (2005) Stimulants: use and abuse in the treatment of”
BackgroundSCHOECHLIN, C., & ENGEL, R. (2005) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2005.04.005 · Cited by 312
Rösler, M., Retz, W., Retz-Junginger, P., Hengesch, G., Schneider, M., Supprian, T., Schwitzgebel, P., Pinhard, K., Dovi–Akue, N., Wender, P., et al. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0516-z · Cited by 305 · cited 2×
“%) screened as being in partial remission of their symptoms (Eyestone and Howell, 1994; Vitelli, 1995; Dalteg and Levander, 1998 II; Dalteg et al., 1999; Rasmussen et al., 2001; Retz et al., 2004; Rosler et al., 2004).”
BackgroundLin, J.-S., Hou, Y., & Jouvet, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14128 · Cited by 300 · cited 1×
“Animal studies show that psychostimulants induce an increase in cFos-like immunoreactivity consistent with it causing neuronal activation in the striatum, including the caudate, and in the mediofrontal cortex (Lin et al., 1996).”
BackgroundTemporal information processing in ADHD: Findings to date and new methods
Toplak, M. E., Dockstader, C., & Tannock, R. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2005.09.018 · Cited by 300
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.6.795 · Cited by 300 · cited 1×
“Court records data indicate that people with ADHD are four to five times more likely to be arrested, and often have a history of multiple arrests and convictions (Satterfield et al., 1982; Hechtman and Weiss, 1986; Lambert, 1988; Mannuzza et al., 1989; Satterfield et al., 1994 II).”
BackgroundA Genomewide Scan for Loci Involved in Attention-Deficit/Hyperactivity Disorder
Fisher, S. E., Francks, C., McCracken, J. T., McGough, J. J., Marlow, A. J., MacPhie, I. L., Newbury, D. F., Crawford, L. R., Palmer, C. G. S., Woodward, J. A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340112 · Cited by 292 · cited 1×
“…ADHD, although there is as yet no clear consensus across the various data sets, and no genes have been identified that account for linkage signals (Fisher et al., 2002; Smalley et al., 2002; Bakker et al., 2003; Ogdie et al., 2003; Arcos-Burgos et al., 2004; Ogdie et al., 2004; Hebebrand et al.,…”
BackgroundHyperactive Boys Almost Grown Up: IV. Criminality and Its Relationship to Psychiatric Status
Mannuzza, S. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810120015004 · Cited by 287 · cited 1×
“Court records data indicate that people with ADHD are four to five times more likely to be arrested, and often have a history of multiple arrests and convictions (Satterfield et al., 1982; Hechtman and Weiss, 1986; Lambert, 1988; Mannuzza et al., 1989; Satterfield et al., 1994 II).”
BackgroundAge-dependent decline of attention deficit hyperactivity disorder
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1143 · Cited by 284 · cited 2×
“%) or adulthood (10–66%; Hill and Schoener, 1996; Spencer et al., 1996; Faraone et al., 1996; Biederman et al., 2000; Barkley, 2002; Faraone et al., 2006).”
BackgroundMethodKahn, R. S., Khoury, J., Nichols, W. C., & Lanphear, B. P. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00208-7 · Cited by 284 · cited 1×
“Gene–environment interactions have been reported between DAT1 and maternal use of tobacco (Kahn et al., 2003) and alcohol (Brookes et al., 2006) during pregnancy on the risk of ADHD, and between catechol O-methyltransferase and low birth weight on risk for antisocial outcomes among ADHD cases…”
BackgroundImpact of comorbidity in adults with attention-deficit/hyperactivity disorder.
Biederman, J. (2004) · PubMed · Cited by 279
Dresel, S., Krause, J., Krause, K.-H., LaFougere, C., Brinkbäumer, K., Kung, H. F., Hahn, K., & Tatsch, K. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000330 · Cited by 278 · cited 4×
“, 2001), is accompanied by reductions in DAT binding to control values (Dresel et al., 2000; Spencer et al., 2005a; Volkow et al., 2005).”
BackgroundInfluentialPrediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report
Jacobsen, L. K., Staley, J. K., Zoghbi, S. S., Seibyl, J. P., Kosten, T. R., Innis, R. B., & Gelernter, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1700 · Cited by 277 · cited 1×
“In addition, there is evidence from two out of four studies that the DAT1 risk genotype for ADHD is associated with increased striatal DAT binding (Heinz et al., 2000; Jacobsen et al., 2000; Martinez et al., 2001; Cheon et al., 2003).”
BackgroundA Controlled Clinical Trial of Bupropion for Attention Deficit Hyperactivity Disorder in Adults
Wilens, T. E., Spencer, T. J., Biederman, J., Girard, K., Doyle, R., Prince, J., Polisner, D., Solhkhah, R., Comeau, S., Monuteaux, M. C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.282 · Cited by 272 · cited 1×
“…et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al., 1999b Ib), and the dopaminergic agent bupropion (Wender and Reimherr, 1990; Wilens et al., 2001 Ib).”
BackgroundTAMM, L., MENON, V., RINGEL, J., & REISS, A. L. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000140452.51205.8d · Cited by 272 · cited 1×
“For example, Tamm et al. (2004) have linked a key deficit – abnormal response inhibition on a Go/No Go task – with abnormal activation patterns in specific temporal regions compared with controls.”
BackgroundBIEDERMAN, J., FARAONE, S. V., MILBERGER, S., JETTON, J. G., CHEN, L., MICK, E., GREENE, R. W., & RUSSELL, R. L. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199609000-00017 · Cited by 270 · cited 3×
“…co-morbid disorders in adulthood include anxiety, depression and antisocial behaviour disorders, and persisting neurodevelopmental disorders such as dyslexia (Heiligenstein and Keeling, 1995; Biederman et al., 1996b; Marks et al., 2001; Biederman, 2004; McGough et al., 2005; Kessler et al., 2006).”
BackgroundAssessment and management of attention-deficit hyperactivity disorder in adults.
Weiss, M. D., & Murray, C. (2003) · Europe PMC (PubMed Central) · Cited by 268
Self-citationKuczenski, R., & Segal, D. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38829-9 · Cited by 267
Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design
Thapar, A., Harrington, R., & McGuffin, P. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.3.224 · Cited by 266 · cited 2×
“ADHD is highly heritable, with heritability estimates from twin studies in the range of 65–90% (Thapar et al., 2001) and average across 20 studies of 76% (Faraone et al., 2005b).”
BackgroundGeller, B., Zimerman, B., Williams, M., Bolhofner, K., Craney, J. L., DelBello, M. P., & Soutullo, C. A. (2000) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460050167269 · Cited by 264 · cited 1×
“In Europe, bipolar disorder is a controversial diagnosis alongside a diagnosis of ADHD in childhood, and yet experts in other areas recognize that children with unstable mood and ADHD symptoms do exist (Geller et al., 2000a, 2000b; Craney and Geller, 2003; Post et al., 2004).”
BackgroundA cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder
Stevenson, C. S., Whitmont, S., Bornholt, L., Livesey, D., & Stevenson, R. J. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01052.x · Cited by 261 · cited 2×
“A retrospective examination of the effects of cognitive remediation found no difference between medicated and unmedicated patients but numbers were small (Stevenson et al., 2002 Ib).”
BackgroundMethodBrandon, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00281-0 · Cited by 259 · cited 1×
“Notably, studies of methylphenidate-treated rats have found that treatment during the equivalent age to human childhood reduces the rewardrelated effects of cocaine (Carlezon et al., 2003), while treatment during the equivalent age to adulthood enhances cocaine reward (Brandon et al., 2001).”
BackgroundBakker, S. C., Meulen, E. M. V. D., Buitelaar, J. K., Sandkuijl, L. A., Pauls, D. L., Monsuur, A. J., Slot, R. V. ‘., Minderaa, R. B., Gunning, W. B., Pearson, P. L., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375143 · Cited by 257 · cited 1×
“…although there is as yet no clear consensus across the various data sets, and no genes have been identified that account for linkage signals (Fisher et al., 2002; Smalley et al., 2002; Bakker et al., 2003; Ogdie et al., 2003; Arcos-Burgos et al., 2004; Ogdie et al., 2004; Hebebrand et al., 2005).”
BackgroundSpencer, T., Biederman, J., Wilens, T., Faraone, S., Prince, J., Gerard, K., Doyle, R., Parekh, A., Kagan, J., & Bearman, S. K. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.775 · Cited by 250 · cited 1×
“…(dextro- or D-amfetamine) (Arnold et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al., 1999b Ib), and the dopaminergic agent bupropion…”
BackgroundEnduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248 · cited 1×
“Notably, studies of methylphenidate-treated rats have found that treatment during the equivalent age to human childhood reduces the rewardrelated effects of cocaine (Carlezon et al., 2003), while treatment during the equivalent age to adulthood enhances cocaine reward (Brandon et al., 2001).”
BackgroundComorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder
Secnik, K., Swensen, A., & Lage, M. J. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523010-00008 · Cited by 247 · cited 1×
“Several co-morbid studies of adults with ADHD have been completed (Kooij et al., 2001; Biederman, 2004; Secnik et al., 2005; Kessler et al., 2005, 2006; Torgersen et al., 2006).”
BackgroundSmalley, S. L., Kustanovich, V., Minassian, S. L., Stone, J. L., Ogdie, M. N., McGough, J. J., McCracken, J. T., MacPhie, I. L., Francks, C., Fisher, S. E., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342732 · Cited by 240 · cited 1×
“…although there is as yet no clear consensus across the various data sets, and no genes have been identified that account for linkage signals (Fisher et al., 2002; Smalley et al., 2002; Bakker et al., 2003; Ogdie et al., 2003; Arcos-Burgos et al., 2004; Ogdie et al., 2004; Hebebrand et al., 2005).”
BackgroundWillcutt, E. G., Pennington, B. F., & DeFries, J. C. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000612)96:3<293::aid-ajmg12>3.0.co;2-c · Cited by 240 · cited 1×
“Mathematical modelling using De Fries and Fulker (DF) analysis supports the hypothesis that ADHD is the extreme of behaviours that vary genetically throughout the entire population (Gjone et al., 1996; Levy et al., 1997; Willcutt et al., 2000; Price et al., 2001).”
MethodSwanson, J. M., Wigal, S. B., Wigal, T., Sonuga-Barke, E., Greenhill, L. L., Biederman, J., Kollins, S., Nguyen, A. S., DeCory, H. H., Hirshe Dirksen, S. J., et al. (2004) · Pediatrics · doi:10.1542/peds.113.3.e206 · Cited by 238 · cited 2×
“Circumstantial evidence exists for sensitization and tolerance, which can be precursors to dependency; in particular, from baseline data of COMACs (Swanson et al., 2004; Sonuga-Barke et al., 2005) and from the titration phase of the MTA (Galanter et al., 2003), in which possible rebound was seen…”
Self-citationRowe, K. S., & Rowe, K. J. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(06)80164-2 · Cited by 236 · cited 1×
“…various dietary manipulations can improve ADHD symptoms in at least some children (Egger et al., 1985; Carter et al., 1993; Boris and Mandel, 1994; Rowe and Rowe, 1994; Schmidt et al., 1997; Dykman and Dykman, 1998; Richardson and Puri, 2002 Ib), although the mechanism of these improvements is…”
BackgroundThe genetics of attention deficit hyperactivity disorder
Thapar, A., O'Donovan, M., & Owen, M. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi263 · Cited by 235
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1147 · Cited by 228 · cited 1×
“Other norepinephrine uptake blocking agents such as desipramine (Wilens et al., 1996 Ib) have similar effects in trials while open studies on venlafaxine report comparable responses (Adler et al., 1995; Hedges et al., 1995; Findling et al., 1996 IIb).”
ResultBrown Attention-Deficit Disorder Scales
(2012) · SpringerReference · doi:10.1007/springerreference_179816 · Cited by 227
Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders
Allen, A. J., Kurlan, R. M., Gilbert, D. L., Coffey, B. J., Linder, S. L., Lewis, D. W., Winner, P. K., Dunn, D. W., Dure, L. S., Sallee, F. R., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000188869.58300.a7 · Cited by 225 · cited 1×
“Although research indicates that there is no statistically significant worsening of tics with stimulants or atomoxetine in children, individuals may nonetheless experience either improvement or deterioration in tics which needs to be treated accordingly (Gadow et al., 1995; Allen et al., 2005).”
BackgroundAttention-Deficit/Hyperactivity Disorder Endophenotypes
Doyle, A. E., Willcutt, E. G., Seidman, L. J., Biederman, J., Chouinard, V.-A., Silva, J., & Faraone, S. V. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.015 · Cited by 224 · cited 1×
“Neuropsychological research, mainly in children, has documented various deficits in executive function (especially inhibition), motivation and reinforcement, attention, timing, memory and energetics (covered in detail in ‘Neuropsychological assessment’ below (Doyle et al., 2005)).”
BackgroundWISC-IV and WISC-III Profiles in Children With ADHD
Mayes, S. D., & Calhoun, S. L. (2006) · Journal of Attention Disorders · doi:10.1177/1087054705283616 · Cited by 223 · cited 1×
“For example, a recent study of the WISC-IV in 118 children showed the working memory tests to be the lowest score in all 118 children, thus lowering the overall IQ score secondary to a deficit considered specific to ADHD (Mayes and Calhoun, 2006).”
ResultOgdie, M. N., Macphie, I. L., Minassian, S. L., Yang, M., Fisher, S. E., Francks, C., Cantor, R. M., McCracken, J. T., McGough, J. J., Nelson, S. F., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375139 · Cited by 220 · cited 1×
“…although there is as yet no clear consensus across the various data sets, and no genes have been identified that account for linkage signals (Fisher et al., 2002; Smalley et al., 2002; Bakker et al., 2003; Ogdie et al., 2003; Arcos-Burgos et al., 2004; Ogdie et al., 2004; Hebebrand et al., 2005).”
BackgroundSymptoms Versus Impairment: The Case for Respecting DSM-IV’s Criterion D
Gordon, M., Antshel, K., Faraone, S., Barkley, R., Lewandowski, L., Hudziak, J. J., Biederman, J., & Cunningham, C. (2006) · Journal of Attention Disorders · doi:10.1177/1087054705283881 · Cited by 219 · cited 1×
“Generic functioning scales have shown poor correlation with ADHD symptoms, making it clear that ADHD specific functional scales are needed (Gordon et al., 2006).”
BackgroundSwanson, C. J., Perry, K. W., Koch-Krueger, S., Katner, J., Svensson, K. A., & Bymaster, F. P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.022 · Cited by 214 · cited 1×
“…administration produced an equivalent threefold increase in prefrontal norepinephrine and dopamine efflux measured by microdialysis (Bymaster et al., 2002), whereas extracellular norepinephrine but not dopamine is increased in other brain regions, including the hippocampus (Swanson et al., 2006).”
BackgroundADHD in adults: A study of clinical characteristics, impairment and comorbidity
Torgersen, T., Gjervan, B., & Rasmussen, K. (2006) · Nordic Journal of Psychiatry · doi:10.1080/08039480500520665 · Cited by 211 · cited 1×
“Several co-morbid studies of adults with ADHD have been completed (Kooij et al., 2001; Biederman, 2004; Secnik et al., 2005; Kessler et al., 2005, 2006; Torgersen et al., 2006).”
BackgroundArcos-Burgos, M., Castellanos, F. X., Pineda, D., Lopera, F., David Palacio, J., Guillermo Palacio, L., Rapoport, J. L., Berg, K., Bailey-Wilson, J. E., & Muenke, M. (2004) · The American Journal of Human Genetics · doi:10.1086/426154 · Cited by 211
Doyle, A. E., Biederman, J., Seidman, L. J., Weber, W., & Faraone, S. V. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.3.477 · Cited by 209 · cited 1×
“…reveal that tests of executive function and attention show good positive predictive power but poor negative predictive power (Barkley et al., 1992; Sharma et al., 1991; Grodzinsky and Barkley, 1999; Rielly et al., 1999; Doyle et al., 2000; Dickerson Mayes et al., 2001; Berlin et al., 2004).”
BackgroundPresenting ADHD symptoms and subtypes in clinically referred adults with ADHD
Millstein, R. B., Wilens, T. E., Biederman, J., & Spencer, T. J. (1997) · Journal of Attention Disorders · doi:10.1177/108705479700200302 · Cited by 207 · cited 4×
“While some symptoms (e.g. hyperactivity) tend to diminish or present differently with age, perhaps due to self-medication, adaptation and neurodevelopment, other symptoms, especially inattention, (Millstein et al., 1998) are more likely to persist and may have a greater impact on adults.”
BackgroundInfluentialDick, D. M., Viken, R. J., Kaprio, J., Pulkkinen, L., & Rose, R. J. (2005) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-005-1829-8 · Cited by 206 · cited 1×
“Several studies also suggest that childhood environmental factors shape the phenotypic expression of ADHD, and comorbidity with other behavioural disorders, by acting on genetic influences (e.g. Hudziak et al., 2005; Burt et al., 2005; Dick et al., 2005; Jester et al., 2005 I–II).”
BackgroundThapar, A., Langley, K., Fowler, T., Rice, F., Turic, D., Whittinger, N., Aggleton, J., Van den Bree, M., Owen, M., & O’Donovan, M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1275 · Cited by 202 · cited 2×
“…have been reported between DAT1 and maternal use of tobacco (Kahn et al., 2003) and alcohol (Brookes et al., 2006) during pregnancy on the risk of ADHD, and between catechol O-methyltransferase and low birth weight on risk for antisocial outcomes among ADHD cases (Thapar et al., 2005b).”
BackgroundGJONE, H., STEVENSON, J., & SUNDET, J. M. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199605000-00013 · Cited by 200 · cited 1×
“Mathematical modelling using De Fries and Fulker (DF) analysis supports the hypothesis that ADHD is the extreme of behaviours that vary genetically throughout the entire population (Gjone et al., 1996; Levy et al., 1997; Willcutt et al., 2000; Price et al., 2001).”
MethodFaraone, S. V., Biederman, J., & Monuteaux, M. C. (2000) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(200001)18:1<1::aid-gepi1>3.0.co;2-x · Cited by 196 · cited 1×
“Family studies report that both parents and siblings of a child with ADHD are around four to five times more likely to have ADHD than the general population (Faraone et al., 2000).”
BackgroundClinical assessment and treatment of attention deficit hyperactivity disorder in adults
Asherson, P. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.4.525 · Cited by 195 · cited 3×
“A package of care needs to be developed from available options on an individual basis after a thorough assessment (Weiss and Murray, 2004; Asherson, 2005, IV).”
BackgroundSelf-citationPrior stimulant treatment in adolescents with bipolar disorder: association with age at onset
DelBello, M. P., Soutullo, C. A., Hendricks, W., Niemeier, R. T., McElroy, S. L., & Strakowski, S. M. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030201.x · Cited by 195 · cited 1×
“One concern in this group is the potential for psychostimulants to enhance the likelihood of psychosis (DelBello et al., 2001), whether in children with prominent mood instability or in those with a strong family history of bipolar disorder.”
BackgroundPharmacology of antidepressants: focus on nefazodone.
DeVane, C. L., Grothe, D. R., & Smith, S. L. (2002) · PubMed · Cited by 189
Taylor, F. B., & Russo, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00015 · Cited by 189 · cited 3×
“Similar but more limited findings are reported for dexamfetamine (dextro- or D-amfetamine) (Arnold et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al.,…”
BackgroundResultCheon, K.-A., Ryu, Y. H., Kim, Y.-K., Namkoong, K., Kim, C.-H., & Lee, J. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1047-3 · Cited by 187 · cited 1×
“In addition, there is evidence from two out of four studies that the DAT1 risk genotype for ADHD is associated with increased striatal DAT binding (Heinz et al., 2000; Jacobsen et al., 2000; Martinez et al., 2001; Cheon et al., 2003).”
BackgroundA guide to the treatment of adults with ADHD.
Weiss, M. D., & Weiss, J. (2004) · The Journal of Clinical Psychiatry · Cited by 186
Self-citationPineda, D., Ardila, A., Rosselli, M., Arias, B. E., Henao, G. C., Gomez, L. F., Mejia, S. E., & Miranda, M. L. (1999) · Journal of Abnormal Child Psychology · doi:10.1023/a:1021932009936 · Cited by 185 · cited 1×
“This latter strategy might present a potential source of gender bias since a focus on conduct disorder and related behaviours might be one explanation of the high male: female ratio among children diagnosed with ADHD (Pineda et al., 1999; Jackson and King, 2004).”
BackgroundSpencer, T. J., Biederman, J., Madras, B. K., Faraone, S. V., Dougherty, D. D., Bonab, A. A., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.036 · Cited by 185 · cited 5×
“While it is not known whether all findings in children can be extrapolated to adults, psychostimulants have comparable effects in adults as in children and adolescents (Faraone et al., 2004; Kooij et al., 2004; Spencer et al., 2005b 1a).”
BackgroundMethodResultInfluentialVolkow, N. D., Wang, G.-J., Fowler, J. S., Fischman, M., Foltin, R., Abumrad, N. N., Gatley, S. J., Logan, J., Wong, C., Gifford, A., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00225-8 · Cited by 184 · cited 1×
“…studies have evaluated the risk/benefit ratio of long-term stimulant medication at therapeutic doses on human brain and behaviour (Volkow and Insel, 2003) – imaging studies indicate that cocaine induces a similar blockade of striatal DAT to that seen with methylphenidate (Volkow et al., 1999).”
ResultMartinez, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00216-5 · Cited by 182 · cited 1×
“In addition, there is evidence from two out of four studies that the DAT1 risk genotype for ADHD is associated with increased striatal DAT binding (Heinz et al., 2000; Jacobsen et al., 2000; Martinez et al., 2001; Cheon et al., 2003).”
BackgroundEpilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective?
Gross-Tsur, V., Manor, O., van der Meere, J., Joseph, A., & Shalev, R. S. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70308-1 · Cited by 181 · cited 1×
“Little research exists in this area, and the research that does exist has studied methylphenidate only (Gross-Tsur et al., 1997; Gucuyener et al., 2003; Tan and Appleton, 2005; van der Feltz-Cornelis and Aldenkamp, 2006).”
BackgroundTAYLOR, F. B., & RUSSO, J. (2000) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2000.10.311 · Cited by 180 · cited 1×
“Similar but more limited findings are reported for dexamfetamine (dextro- or D-amfetamine) (Arnold et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al.,…”
ResultIncidence and costs of accidents among attention-deficit/hyperactivity disorder patients
Swensen, A., Birnbaum, H. G., Ben Hamadi, R., Greenberg, P., Cremieux, P.-Y., & Secnik, K. (2004) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2003.12.003 · Cited by 180
Methylphenidate Effects on Symptoms of Attention Deficit Disorder in Adults
Mattes, J. A. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220049008 · Cited by 177 · cited 2×
“CMAJ 18: 715–722 Weiss M D, Murray C (2004) Practice Guideline for the Assessment of ADHD in adults.”
BackgroundPratt, T. C., Cullen, F. T., Blevins, K. R., Daigle, L., & Unnever, J. D. (2002) · International Journal of Police Science & Management · doi:10.1350/ijps.4.4.344.10873 · Cited by 173 · cited 1×
“ADHD is a common factor associated with delinquency, adult criminal behaviour in men and women and recidivism (Bambinski et al., 1999; Pratt et al., 2002; Brassett-Grundy and Butler, 2004a, Recommendations – people with learning disabilities (LD) • ADHD is more commonly found in people with LD, and…”
BackgroundSmith, B. H., Waschbusch, D. A., Willoughby, M. T., & Evans, S. W. (2000) · Clinical Child and Family Psychology Review · doi:10.1023/a:1026477121224 · Cited by 171 · cited 2×
“Berner M, Ebert D (2002) Psychotherapy of attention deficit hyperac-”
BackgroundEffects of a few food diet in attention deficit disorder.
Carter, C. M., Urbanowicz, M., Hemsley, R., Mantilla, L., Strobel, S., Graham, P. J., & Taylor, E. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.69.5.564 · Cited by 171 · cited 1×
“In terms of treatment, various dietary manipulations can improve ADHD symptoms in at least some children (Egger et al., 1985; Carter et al., 1993; Boris and Mandel, 1994; Rowe and Rowe, 1994; Schmidt et al., 1997; Dykman and Dykman, 1998; Richardson and Puri, 2002 Ib), although the mechanism of…”
BackgroundSelf-citationLingford-Hughes, A. R., Welch, S., & Nutt, D. J. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800321 · Cited by 167 · cited 1×
“Recent guidelines have covered management of bipolar disorder (Goodwin, 2003) and drug treatments for addiction (Lingford-Hughes et al., 2004), with guidelines on anxiety published late last year (Baldwin et al., 2005).”
BackgroundSelf-citationGucuyener, K., Erdemoglu, A. K., Senol, S., Serdaroglu, A., Soysal, S., & Kockar, I. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180020601 · Cited by 166 · cited 1×
“Little research exists in this area, and the research that does exist has studied methylphenidate only (Gross-Tsur et al., 1997; Gucuyener et al., 2003; Tan and Appleton, 2005; van der Feltz-Cornelis and Aldenkamp, 2006).”
BackgroundKOOIJ, J. J. S., BURGER, H., BOONSTRA, A. M., VAN DER LINDEN, P. D., KALMA, L. E., & BUITELAAR, J. K. (2004) · Psychological Medicine · doi:10.1017/s0033291703001776 · Cited by 163 · cited 1×
“While it is not known whether all findings in children can be extrapolated to adults, psychostimulants have comparable effects in adults as in children and adolescents (Faraone et al., 2004; Kooij et al., 2004; Spencer et al., 2005b 1a).”
BackgroundParkes, J. (1981) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.9.857 · Cited by 162
Levin, F. R., Evans, S. M., McDowell, D. M., & Kleber, H. D. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0605 · Cited by 161 · cited 1×
“…trials have examined the effects of treatment in adults with substance use disorder but methylphenidate has been used effectively in cocaine users (Levin et al., 1998 Ib), while history of drug Recommendations – co-morbid conditions • Clinicians need to screen for autistic spectrum, developmental…”
BackgroundA genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs
Hebebrand, J., Dempfle, A., Saar, K., Thiele, H., Herpertz-Dahlmann, B., Linder, M., Kiefl, H., Remschmidt, H., Hemminger, U., Warnke, A., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001761 · Cited by 160 · cited 1×
“Four linkage scans have been completed and highlight a number of potential chromosomal regions containing genes that increase risk for ADHD, although there is as yet no clear consensus across the various data sets, and no genes have been identified that account for linkage signals (Fisher et al., 2002; Smalley et al.,…”
BackgroundLambert, N. M. (1988) · American Psychologist · doi:10.1037//0003-066x.43.10.786 · Cited by 159 · cited 1×
“Court records data indicate that people with ADHD are four to five times more likely to be arrested, and often have a history of multiple arrests and convictions (Satterfield et al., 1982; Hechtman and Weiss, 1986; Lambert, 1988; Mannuzza et al., 1989; Satterfield et al., 1994 II).”
BackgroundDopamine Transporter Genotype and Methylphenidate Dose Response in Children with ADHD
Stein, M. A., Waldman, I. D., Sarampote, C. S., Seymour, K. E., Robb, A. S., Conlon, C. J., Kim, S., & Cook, E. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300718 · Cited by 157 · cited 1×
“The effect of genotype on treatment response is unclear, although a poor response to methylphenidate has been reported in children homozygous for the less common nine-repeat DAT1 genotype (Stein et al., 2005).”
BackgroundAdler, L. A., Spencer, T. J., Milton, D. R., Moore, R. J., & Michelson, D. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0304 · Cited by 157 · cited 3×
“However, effects on overall functioning are debated, while no long-term efficacy trials have yet been reported, although an interim analysis in adults has been reported (Adler et al., 2005a).”
BackgroundMethodHechtman, L., & Weiss, G. (1986) · The Canadian Journal of Psychiatry · doi:10.1177/070674378603100614 · Cited by 156 · cited 1×
“Court records data indicate that people with ADHD are four to five times more likely to be arrested, and often have a history of multiple arrests and convictions (Satterfield et al., 1982; Hechtman and Weiss, 1986; Lambert, 1988; Mannuzza et al., 1989; Satterfield et al., 1994 II).”
BackgroundFoods and additives are common causes of the attention deficit hyperactive disorder in children.
Boris, M., & Mandel, F. S. (1994) · PubMed · Cited by 155
Hyperactives as young adults: Past and current substance abuse and antisocial behavior.
Hechtman, L., Weiss, G., & Perlman, T. (1984) · American Journal of Orthopsychiatry · doi:10.1111/j.1939-0025.1984.tb01507.x · Cited by 154
Kratochvil, C. J., Newcorn, J. H., Arnold, L. E., Duesenberg, D., Emslie, G. J., Quintana, H., Sarkis, E. H., Wagner, K. D., Gao, H., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000169012.81536.38 · Cited by 152 · cited 1×
“Recent clinical trials have demonstrated that patients with co-morbid ADHD and anxiety or tics may show improvement in both disorders with atomoxetine (Kratochvil et al., 2005).”
BackgroundBerlin, L., Bohlin, G., Nyberg, L., & Janols, L.-O. (2004) · Child Neuropsychology · doi:10.1076/chin.10.1.1.26243 · Cited by 152 · cited 2×
“, 1999) most studies in children reveal that tests of executive function and attention show good positive predictive power but poor negative predictive power (Barkley et al., 1992; Sharma et al., 1991; Grodzinsky and Barkley, 1999; Rielly et al., 1999; Doyle et al., 2000; Dickerson Mayes et al., 2001; Berlin et al., 2…”
BackgroundAvery, R. A., Franowicz, J. S., Studholme, C., van Dyck, C. H., & Arnsten, A. F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00111-1 · Cited by 151 · cited 1×
“Furthermore, adrenoceptor agonists (guanfacine and clonidine), which are thought to activate prefrontal cortex postsynaptic alpha2 adrenoceptors, have been shown to improve performance of non-human primates in a spatial working memory task (Avery et al., 2000).”
BackgroundGalanter, C. A., Carlson, G. A., Jensen, P. S., Greenhill, L. L., Davies, M., Li, W., Chuang, S. Z., Elliott, G. R., Arnold, L. E., March, J. S., et al. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322163844 · Cited by 146 · cited 4×
“…which can be precursors to dependency; in particular, from baseline data of COMACs (Swanson et al., 2004; Sonuga-Barke et al., 2005) and from the titration phase of the MTA (Galanter et al., 2003), in which possible rebound was seen that might be due to tolerance (Sonuga-Barke et al., 2004).”
BackgroundInfluentialSteele, M. M., Weiss, M. D., Swanson, J. M., Wang, J., Prinzo, R., & Binder, C. E. (2006) · PubMed · Cited by 145
Self-citationWaldman, I. D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.002 · Cited by 141 · cited 1×
“…– e.g. delay aversion, executive motor inhibition, deficit in arousal/activation regulation) that may underpin symptoms and behaviours, with neurobiological changes (e.g. dysfunction in frontostriatal circuitry, reward systems and catecholamine function (Waldman, 2005; Willcutt et al., 2005)).”
BackgroundPredictive Power of Frontal Lobe Tests in the Diagnosis of Attention Deficit Hyperactivity Disorder
Grodzinsky, G. M., & Barkley, R. A. (1999) · The Clinical Neuropsychologist · doi:10.1076/clin.13.1.12.1983 · Cited by 140 · cited 1×
“…reveal that tests of executive function and attention show good positive predictive power but poor negative predictive power (Barkley et al., 1992; Sharma et al., 1991; Grodzinsky and Barkley, 1999; Rielly et al., 1999; Doyle et al., 2000; Dickerson Mayes et al., 2001; Berlin et al., 2004).”
BackgroundAman, M. G., Buican, B., & Arnold, L. E. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603321666171 · Cited by 140 · cited 1×
“Those studies of LD children have been small scale, of short duration and have limited follow-up (Mayes et al., 1994; Handen et al., 1999; Aman et al., 2003 Ib).”
BackgroundUnaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder
van Dyck, C. H., Quinlan, D. M., Cretella, L. M., Staley, J. K., Malison, R. T., Baldwin, R. M., Seibyl, J. P., & Innis, R. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.309 · Cited by 139 · cited 1×
“Several neuroimaging studies, though not all (van Dyck et al., 2002), have indicated that striatal DAT binding is increased compared with controls in ADHD patients (Krause et al., 2000; Madras et al., 2002; Spencer et al., 2005a; Volkow et al., 2005) including studies in adults (Dougherty et al.,…”
Bupropion treatment of attention-deficit hyperactivity disorder in adults
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.8.1018 · Cited by 138 · cited 1×
“…et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al., 1999b Ib), and the dopaminergic agent bupropion (Wender and Reimherr, 1990; Wilens et al., 2001 Ib).”
BackgroundAge-dependent expression of attention-deficit/hyperactivity disorder symptoms
Mick, E. O., Faraone, S. V., & Biederman, J. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.01.003 · Cited by 135 · cited 2×
“Several major prospective follow-up studies have documented the natural history of ADHD, especially as patients transit through adolescence into adulthood (Hechtman and Weiss, 1983; Barkley et al., 1990; Weiss and Hechtman, 1993; Biederman et al., 1996a; Biederman et al., 1996b; Faraone et al., 1996; Biederman et al.,…”
BackgroundLOVEJOY, D. W., BALL, J. D., KEATS, M., STUTTS, M. L., SPAIN, E. H., JANDA, L., & JANUSZ, J. (1999) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617799533055 · Cited by 135 · cited 1×
“While little is known about the value of neuropsychological assessment in differential diagnosis in adults and adolescents (Lovejoy et al., 1999) most studies in children reveal that tests of executive function and attention show good positive predictive power but poor negative predictive power…”
BackgroundOgdie, M. N., Fisher, S. E., Yang, M., Ishii, J., Francks, C., Loo, S. K., Cantor, R. M., McCracken, J. T., McGough, J. J., Smalley, S. L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/424387 · Cited by 133
Efficacy of Methylphenidate Among Preschool Children With Developmental Disabilities and ADHD
Handen, B. L., Feldman, H. M., Lurier, A., & Murray, P. J. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199907000-00009 · Cited by 128 · cited 2×
“Lower doses of methylphenidate (0.3mg/kg/dose) appear to be better tolerated in LD children (Handen et al., 1999 Ib).”
BackgroundVenlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.
Findling, R. L., SCHWARTZ, M. A., Flannery, D. J., & Manos, M. J. (1996) · PubMed · Cited by 128
Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder
RHODES, S. M., COGHILL, D. R., & MATTHEWS, K. (2005) · Psychological Medicine · doi:10.1017/s0033291705004599 · Cited by 126 · cited 2×
“…mechanisms (Willcutt et al., 2005), altered reward or motivational pathways (Luman et al., 2005), abnormal processing of time-related cues (Toplak and Tannock, in submission), non-working memory (Rhodes et al., 2004, 2005) and diffuse abnormalities in energetics (Seargant, 2005).”
BackgroundSelf-citationCraney, J. L., & Geller, B. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00044.x · Cited by 125 · cited 1×
“In Europe, bipolar disorder is a controversial diagnosis alongside a diagnosis of ADHD in childhood, and yet experts in other areas recognize that children with unstable mood and ADHD symptoms do exist (Geller et al., 2000a, 2000b; Craney and Geller, 2003; Post et al., 2004).”
BackgroundRATEY, J. J., GREENBERG, M. S., BEMPORAD, J. R., & LINDEM, K. J. (1992) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1992.2.267 · Cited by 125
Hechtman, L. T., & Greenfield, B. J. (2003) · Pediatric Drugs · doi:10.2165/00148581-200305120-00002 · Cited by 123 · cited 1×
“The long-term effects were reviewed in an analysis of existing short- and longterm follow-up studies of stimulants in children with ADHD (Hechtman and Greenfield, 2003).”
BackgroundKollins, S. H. (2003) · PubMed · Cited by 123
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder
Fone, K. C. F., & Nutt, D. J. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.10.001 · Cited by 122 · cited 1×
“Mechanisms of drug action All effective agents thus far identified act on dopamine and/or norepinephrine neurotransmission, either as agonists or as reuptake inhibitors with the exception of modafinil, whose mechanism of action remains unclear (Fone and Nutt, 2005).”
BackgroundSelf-citationEyestone, L. L., & Howell, R. J. (1994) · PubMed · Cited by 122
Faraone, S. V., Biederman, J., Mennin, D. S., Gershon, J., & Tsuang, M. T. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00013 · Cited by 121 · cited 2×
“%) or adulthood (10–66%; Hill and Schoener, 1996; Spencer et al., 1996; Faraone et al., 1996; Biederman et al., 2000; Barkley, 2002; Faraone et al., 2006).”
BackgroundWhat are the long-term effects of methylphenidate treatment?
Volkow, N. D., & Insel, T. R. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.019 · Cited by 121 · cited 1×
“Very few clinical studies have evaluated the risk/benefit ratio of long-term stimulant medication at therapeutic doses on human brain and behaviour (Volkow and Insel, 2003) – imaging studies indicate that cocaine induces a similar blockade of striatal DAT to that seen with methylphenidate (Volkow…”
ResultRetz, W., Retz‐Junginger, P., Hengesch, G., Schneider, M., Thome, J., Pajonk, F., Salahi-Disfan, A., Rees, O., Wender, P. H., & R�sler, M. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0470-9 · Cited by 120 · cited 2×
“%) screened as being in partial remission of their symptoms (Eyestone and Howell, 1994; Vitelli, 1995; Dalteg and Levander, 1998 II; Dalteg et al., 1999; Rasmussen et al., 2001; Retz et al., 2004; Rosler et al., 2004).”
BackgroundGALLAGHER, R., & BLADER, J. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05778.x · Cited by 119
Rasmussen, K. B., Almvik, R., & Levander, S. E. (2001) · PubMed · Cited by 119
Arnold, L. E., Kleykamp, D., Votolato, N. A., Taylor, W. A., Kontras, S. B., & Tobin, K. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90167-4 · Cited by 118 · cited 2×
“Similar but more limited findings are reported for dexamfetamine (dextro- or D-amfetamine) (Arnold et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al.,…”
ResultWhither causal models in the neuroscience of ADHD?
Coghill, D., Nigg, J., Rothenberger, A., Sonuga‐Barke, E., & Tannock, R. (2005) · Developmental Science · doi:10.1111/j.1467-7687.2005.00397.x · Cited by 116 · cited 3×
“Key uncertainties • A better aetiological theory is needed that accounts for the causal heterogeneity in the condition (Coghill et al., 2005; Sonuga- Barke, 2005) • Is ADHD a categorical difference or the end of spectrum of a population trait?”
BackgroundSelf-citationSatterfield, J. H., Swanson, J. M., Schell, A. M., & LEE, F. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199402000-00005 · Cited by 115 · cited 1×
“Court records data indicate that people with ADHD are four to five times more likely to be arrested, and often have a history of multiple arrests and convictions (Satterfield et al., 1982; Hechtman and Weiss, 1986; Lambert, 1988; Mannuzza et al., 1989; Satterfield et al., 1994 II).”
BackgroundAdult attention deficit hyperactivity disorder and the dopamine D4 receptor gene
Muglia, P., Jain, U., Macciardi, F., & Kennedy, J. L. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000612)96:3<273::aid-ajmg7>3.0.co;2-z · Cited by 115 · cited 2×
“Although most studies have focused on children with ADHD, it is interesting to note that the only two studies to investigate the DRD4 association in adults with ADHD were both positive (Muglia et al., 2000; Lynn et al., 2005).”
BackgroundMurphy, K. R., & Barkley, R. A. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080159 · Cited by 114 · cited 1×
“Some evidence suggests that equal numbers of women and men are affected with ADHD as adults (Murphy and Barkley, 1996; Rowland et al., 2002), which raises the possibility that girls with ADHD are underdiagnosed.”
BackgroundLong-term outcome of hyperactive children.
Hechtman, L., & Weiss, G. (1983) · American Journal of Orthopsychiatry · doi:10.1111/j.1939-0025.1983.tb03397.x · Cited by 113 · cited 2×
“…major prospective follow-up studies have documented the natural history of ADHD, especially as patients transit through adolescence into adulthood (Hechtman and Weiss, 1983; Barkley et al., 1990; Weiss and Hechtman, 1993; Biederman et al., 1996a; Biederman et al., 1996b; Faraone et al., 1996;…”
BackgroundRush, A. J., & FRANCES, A. J. (2000) · PubMed · Cited by 109
Presentation of Unrecognized Attention Deficit Hyperactivity Disorder in College Students
Heiligenstein, E., & Keeling, R. P. (1995) · Journal of American College Health · doi:10.1080/07448481.1995.9940481 · Cited by 108 · cited 1×
“…co-morbid disorders in adulthood include anxiety, depression and antisocial behaviour disorders, and persisting neurodevelopmental disorders such as dyslexia (Heiligenstein and Keeling, 1995; Biederman et al., 1996b; Marks et al., 2001; Biederman, 2004; McGough et al., 2005; Kessler et al., 2006).”
BackgroundRemschmidt, H. (2005) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-005-0439-x · Cited by 108
Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., & Glatt, S. J. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-16 · Cited by 108
The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)
Madras, B. K., Miller, G. M., & Fischman, A. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00439-9 · Cited by 107 · cited 1×
“…not all (van Dyck et al., 2002), have indicated that striatal DAT binding is increased compared with controls in ADHD patients (Krause et al., 2000; Madras et al., 2002; Spencer et al., 2005a; Volkow et al., 2005) including studies in adults (Dougherty et al., 1999; Dresel et al., 2000; Krause et…”
Temperament and Character Profiles and the Dopamine D4 Receptor Gene in ADHD
Lynn, D. E., Lubke, G., Yang, M., McCracken, J. T., McGough, J. J., Ishii, J., Loo, S. K., Nelson, S. F., & Smalley, S. L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.906 · Cited by 104 · cited 1×
“Although most studies have focused on children with ADHD, it is interesting to note that the only two studies to investigate the DRD4 association in adults with ADHD were both positive (Muglia et al., 2000; Lynn et al., 2005).”
BackgroundRhodes, S., Coghill, D., & Matthews, K. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1833-7 · Cited by 103 · cited 2×
“…mechanisms (Willcutt et al., 2005), altered reward or motivational pathways (Luman et al., 2005), abnormal processing of time-related cues (Toplak and Tannock, in submission), non-working memory (Rhodes et al., 2004, 2005) and diffuse abnormalities in energetics (Seargant, 2005).”
BackgroundSelf-citationDSM-IV and ICD-10: A Comparison of the Correlates of ADHD and Hyperkinetic Disorder
Tripp, G., Luk, S. L., Schaughency, E. A., & Singh, R. K. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199902000-00014 · Cited by 102 · cited 9×
“Two shorter scales have been developed to allow a rapid initial screen in various clinical settings, and are based on the 18 symptoms listed in both the DSM-IV-TR and the ICD-10 DCR criteria.”
BackgroundInfluentialImpact of psychostimulants on vesicular monoamine transporter function
Fleckenstein, A. E., & Hanson, G. R. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.077 · Cited by 101 · cited 1×
“…cross the cell membrane by a mechanism independent of the transporter, and interact with the vesicular monoamine transporter 2 (VMAT2), thereby displacing vesicular dopamine and causing the release of newly synthesized intraneuronal monoamine (Ferris and Tang, 1979; Fleckenstein and Hanson, 2003).”
BackgroundMagnússon, P., Smári, J., Sigurðardóttir, D., Baldursson, G., Sigmundsson, J., Kristjánsson, K., Sigurðardóttir, S., Hreiðarsson, S., Sigurbjörnsdóttir, S., & Guðmundsson, Ó. Ó. (2006) · Journal of Attention Disorders · doi:10.1177/1087054705283650 · Cited by 100 · cited 2×
“Maidment I D (2003a) Efficacy of stimulants in adult ADHD.”
BackgroundGender Differences in the Effects of Oppositional Behavior on Teacher Ratings of ADHD Symptoms
Jackson, D. A., & King, A. R. (2004) · Research on Child and Adolescent Psychopathology · doi:10.1023/b:jacp.0000019772.71251.ff · Cited by 99 · cited 1×
“This latter strategy might present a potential source of gender bias since a focus on conduct disorder and related behaviours might be one explanation of the high male: female ratio among children diagnosed with ADHD (Pineda et al., 1999; Jackson and King, 2004).”
BackgroundSix-Month Stability and Outcome of a Prepubertal and Early Adolescent Bipolar Disorder Phenotype
Geller, B., Zimerman, B., Williams, M., Bolhofner, K., Craney, J. L., DelBello, M. P., & Soutullo, C. A. (2000) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460050167278 · Cited by 95 · cited 1×
“In Europe, bipolar disorder is a controversial diagnosis alongside a diagnosis of ADHD in childhood, and yet experts in other areas recognize that children with unstable mood and ADHD symptoms do exist (Geller et al., 2000a, 2000b; Craney and Geller, 2003; Post et al., 2004).”
BackgroundNeuropsychological function in adults with attention-deficit/hyperactivity disorder
Seidman, L. J., Doyle, A., Fried, R., Valera, E., Crum, K., & Matthews, L. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2003.12.005 · Cited by 95 · cited 1×
“The limited liter- ature in adults reports similar patterns, although marked heterogeneity exists (Schoeclin and Engel, 2005; Frazier et al., 2004; Harvey et al., 2004; Seidman et al., 2004; Nigg, 2005).”
Cognitive Therapy in the Treatment of Adults With ADHD: A Systematic Chart Review of 26 Cases
Wilens, T. E., McDermott, S. P., Biederman, J., Abrantes, A., Hahesy, A., & Spencer, T. J. (1999) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.13.3.215 · Cited by 94 · cited 2×
“…et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al., 1999b Ib), and the dopaminergic agent bupropion (Wender and Reimherr, 1990; Wilens et al., 2001 Ib).”
BackgroundGADOW, K. D., NOLAN, E., SPRAFKIN, J., & SVERD, J. (1995) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199506000-00004 · Cited by 94 · cited 1×
“Although research indicates that there is no statistically significant worsening of tics with stimulants or atomoxetine in children, individuals may nonetheless experience either improvement or deterioration in tics which needs to be treated accordingly (Gadow et al., 1995; Allen et al., 2005).”
BackgroundSantosh, P. J., & Taylor, E. (2000) · European Child & Adolescent Psychiatry · doi:10.1007/s007870070017 · Cited by 94
Self-citationHudziak, J. J., Derks, E. M., Althoff, R. R., Rettew, D. C., & Boomsma, D. I. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1614 · Cited by 93 · cited 1×
“Several studies also suggest that childhood environmental factors shape the phenotypic expression of ADHD, and comorbidity with other behavioural disorders, by acting on genetic influences (e.g. Hudziak et al., 2005; Burt et al., 2005; Dick et al., 2005; Jester et al., 2005 I–II).”
BackgroundDoes oligoantigenic diet influence hyperactive/conduct-disordered children ? a controlled trial
Schmidt, M. H., M�cks, P., Lay, B., Eisert, H. G., Fojkar, R., Fritz-Sigmund, D., Marcus, A., & Musaeus, B. (1997) · European Child & Adolescent Psychiatry · doi:10.1007/bf00566671 · Cited by 90 · cited 1×
“…dietary manipulations can improve ADHD symptoms in at least some children (Egger et al., 1985; Carter et al., 1993; Boris and Mandel, 1994; Rowe and Rowe, 1994; Schmidt et al., 1997; Dykman and Dykman, 1998; Richardson and Puri, 2002 Ib), although the mechanism of these improvements is unknown.”
Background
Research works printed but not linked: 20
- Alsop M (2005) Equality in Justice, ADHD Across the Lifespan. Dorset ADHD Support Group, Weymouth (www.dorsetadhd.org.uk)
- American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders version IV text revision. American Psychiatric Association, Washington DC
- 10.1177/026988110001400101 · DOI · Paper page
- 10.1111/1469-7610.00452 · doi:10.1111/1469-7610.00452 · Paper page
- Biederman J , Spencer T J (2001) Psychopharmacology of adults with attention-deficit/hyperactivity disorder . Primary Psychiatry 11: 57-62
- Bloom B , Dey A N (2004) Summary health statistics for U.S. children: National Health Interview Survey . Vital Health Stat 10: 1-85
- Brassett-Grundy A , Butler N (2004a) Attention-Deficit/Hyperactivity Disorder: An overview and review of the literature relating to the correlates and lifecourse outcomes for males and females. Bedford Group for Lifecourse and Statistical Studies Occasional Paper: No. 1. Institute of Education, University of London
- Brassett-Grundy A , Butler N (2004b) Prevalence and Adult Outcomes of Attention-Deficit/Hyperactivity Disorder: Evidence from a 30-year prospective longitudinal study. Bedford Group for Lifecourse and Statistical Studies Occasional Paper: No. 2. Institute of Education, University of London
- Coghill D (2006) Making the most of scant resources. In Yule W (ed.), The ADHD Spectrum. ACAMH Occasional papers 24, ACAMH, London
- Conners C K , Erhardt D , Sparrow E , Conners M A (1998) CAARS Adult ADHD Rating Scales. Multi Health Systems Inc., New York
- Gadow K , Sprafkin J , Weiss M (1999) Adult Inventories-4. Available at: www.checkmateplus.com
- 10.1037/0003-066X.43.10.786 · doi:10.1037/0003-066x.43.10.786 · Paper page
- 10.1080/j.1440-1614.1999.00590.x · doi:10.1080/j.1440-1614.1999.00590.x · Paper page
- Ward M F , Wender P H , Reimherr F W (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder . Am J Psychiatry 150: 885-890 .
- Weiss M D , Murray C (2004) Practice Guideline for the Assessment of ADHD in adults. Canadian ADHD Resource Alliance, Vancouver, Canada
- WHO (1992) The ICD-10 classification of mental and behavioural disorders. Geneva, Switzerland
- World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
- Young S J , Gudjonsson G (submitted) Growing out of attention-deficit/hyperactivity disorder: the relationship between functioning and symptoms
- Young S J , Ross R R (2006) R&R2 for ADHD youth and adults. A handbook for teaching prosocial competence. Cognitive Centre of Canada, Ottawa (cogcen@canada.com)
- Young S J , Ross R R (in preparation) R&R2 for ADHD children. A handbook for teaching prosocial competence
Cited by
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“now recommend that ADHD should be recognised and appropriately treated throughout the lifespan [32-34].”
Self-citationShaw, M., Hodgkins, P., Caci, H., Young, S., Kahle, J., Woods, A. G., & Arnold, L. E. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-99 · Cited by 759
“Several of these organizations recognize a need for further study of the long-term consequences of ADHD and of its treatment [22,29,30,32,33].”
BackgroundSelf-citationUpdated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686
Self-citationLive fast, die young? A review on the developmental trajectories of ADHD across the lifespan
Franke, B., Michelini, G., Asherson, P., Banaschewski, T., Bilbow, A., Buitelaar, J. K., Cormand, B., Faraone, S. V., Ginsberg, Y., Haavik, J., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.08.001 · Cited by 643
Self-citationWilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Self-citation
Metadata
- Authors
- Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., Weiss, M., & Young, S.
- Affiliations
- University of Bristol (GB)
- University of Nottingham (GB)
- King's College London (GB)
- Telford & Wrekin PCT, Shrewsbury, UK
- London, UK
- University of Dundee (GB)
- Institute of Psychiatry, London, UK
- University of Southampton (GB)
- University of British Columbia (CA)
- Bethlem Royal Hospital (GB)
- Corresponding author
- Nutt, D. J.
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2007-01
- Volume
- 21
- Issue
- 1
- Pages
- 10-41
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2006463161
- Semantic Scholar
- 601bde001c8005e8fae1acf04b12ce0b33b7db90
- Cited by
- 259
- References
- 242
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 10 · 2020: 8 · 2019: 5 · 2018: 8 · 2017: 12 · 2016: 13 · 2015: 12 · 2014: 28 · 2013: 28 · 2012: 37
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Adolescent and Pediatric Healthcare
- Keywords
- attention deficit hyperactivity disorder, adult ADHD, adolescents, transition to adult services, stimulant medication, psychopharmacological treatment, primary care, consensus recommendations
- MeSH terms
- Adolescent, Adult, Age Factors, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, United Kingdom, Health Services Needs and Demand, Humans, Mental Health Services, Primary Health Care, Psychiatric Status Rating Scales, Comorbidity, Adolescent Health Services, Models, Organizational, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.